Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (1015)	4/27/2007 11:43:09 AM
From: Rocky9	Read Replies (1) \| Respond to of 3027

Yes, I meant last week. I did have some long shares to cover with May 17.50 calls (to go with the sold May 12.50 puts). I did not cover all of the long shares (plus I didn't sell all of my long June 20 calls, which have lost over 50% of their value in the last week). The stock is still pretty strong. I hope to be able to roll the May 17.50s out and up, but I will be glad to keep the premiums as long as the stock doesn't head below 15.

To: Robohogs who wrote (1015)	4/29/2007 8:57:30 PM
From: tom pope	Read Replies (2) \| Respond to of 3027

Jon, I thought you might be interested in this article on Nassim Taleb, which I found on one of the energy threads. Taleb only buys out of the money options, never writes them, because he's looking for the odd event that destroys option sellers like Niederhoffer. I read Taleb's book "Fooled by Randomness" some time ago - it's one of those books that is too long even though it's fairly short. Taleb comes across as pompous and arrogant (he's a quant) but the article is a fun read. gladwell.com